OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effects of GLP-1RA and SGLT2i, Alone or in Combination, on Mouse Models of Type 2 Diabetes Representing Different Disease Stages
Masao Koike, Hitoki Saito, Genta Kohno, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11463-11463
Open Access | Times Cited: 7
Masao Koike, Hitoki Saito, Genta Kohno, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11463-11463
Open Access | Times Cited: 7
Showing 7 citing articles:
Glucagon-Like Peptide-1 Protects Against Atrial Fibrillation and Atrial Remodeling in Type 2 Diabetic Mice
Loryn J. Bohne, Hailey J. Jansen, Tristan W. Dorey, et al.
JACC Basic to Translational Science (2023) Vol. 8, Iss. 8, pp. 922-936
Open Access | Times Cited: 25
Loryn J. Bohne, Hailey J. Jansen, Tristan W. Dorey, et al.
JACC Basic to Translational Science (2023) Vol. 8, Iss. 8, pp. 922-936
Open Access | Times Cited: 25
Gut Microbiota−Tryptophan Metabolism−GLP-1 Axis Participates in β-Cell Regeneration Induced by Dapagliflozin
Yafei Jiang, Jin Yang, Xia Li, et al.
Diabetes (2024) Vol. 73, Iss. 6, pp. 926-940
Open Access | Times Cited: 10
Yafei Jiang, Jin Yang, Xia Li, et al.
Diabetes (2024) Vol. 73, Iss. 6, pp. 926-940
Open Access | Times Cited: 10
Cardiometabolic Phenotype in HFpEF: Insights from Murine Models
Ekaterina Ogurtsova, T. I. Arefieva, A. Yu. Filatova, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 744-744
Open Access
Ekaterina Ogurtsova, T. I. Arefieva, A. Yu. Filatova, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 744-744
Open Access
Combination therapies in nonalcoholic fatty liver disease using antidiabetic and disease-specific drugs
Evgenia Koureta
Annals of Gastroenterology (2023)
Open Access | Times Cited: 4
Evgenia Koureta
Annals of Gastroenterology (2023)
Open Access | Times Cited: 4
Therapy Combining Glucagon-Like Peptide-1 Receptor Agonist with Sodium-Glucose Cotransporter 2 Inhibitor Suppresses Atherosclerosis in Diabetic ApoE-Deficient Mice
Masahiro Takubo, Kentaro Watanabe, Hitoki Saito, et al.
Experimental and Clinical Endocrinology & Diabetes (2024) Vol. 132, Iss. 09, pp. 507-514
Closed Access
Masahiro Takubo, Kentaro Watanabe, Hitoki Saito, et al.
Experimental and Clinical Endocrinology & Diabetes (2024) Vol. 132, Iss. 09, pp. 507-514
Closed Access
Animal studies of sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease
Evangelia Makri, Eleftheria Makri, A. Goulas, et al.
Annals of Gastroenterology (2024)
Open Access
Evangelia Makri, Eleftheria Makri, A. Goulas, et al.
Annals of Gastroenterology (2024)
Open Access
Efficacy and Safety of Switching from Sitagliptin to Ipragliflozin in Obese Japanese Patients with Type 2 Diabetes Mellitus: A Single-Arm Multicenter Interventional Study
Kentaro Watanabe, Susumu Yamaguchi, Yoshinori Kosakai, et al.
Clinical Drug Investigation (2023) Vol. 43, Iss. 12, pp. 927-937
Closed Access | Times Cited: 1
Kentaro Watanabe, Susumu Yamaguchi, Yoshinori Kosakai, et al.
Clinical Drug Investigation (2023) Vol. 43, Iss. 12, pp. 927-937
Closed Access | Times Cited: 1
